Advancing Neoadjuvant Therapy with Inetetamab for HER2-Positive Breast Cancer. Zhou W, Ding Q. Cancer Lett 2025 Jun 5:217852. doi: 10.1016/j.canlet.2025.217852.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhou W, Ding Q. Advancing Neoadjuvant Therapy with Inetetamab for HER2-Positive Breast Cancer. Cancer Lett 2025 Jun 5:217852. doi: 10.1016/j.canlet.2025.217852.
PMID: 40482910